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Intent of The Study 
Glutamine lies at the center of cellular nitrogen metabolism; 
glutaminase is the major enzyme facilitating use of the amide mitrogen 
for a wide variety of biochemical substances. This work was devoted to 
the characterization of glutaminase. 
There is no up-towdate review on glutaminase available. The 
REVIEW OF LITERATURE is an attempt to accomplish that purpose. This 
chapter not only summarizes previous works on glutaminase, but also 
indicates the controversies among workers. The sections are arranged 
in such a way that the reader can easily compare the experimental 
results of this work with those of previous works. 
All of the critical experiments are described in detail, including 
the methods for setting them up, in order to enable the reader to judge 
the validity of the experiments as well as to repeat them. To minimize 
distraction in reading and to provide a compact picture of this work, 
results and discussion are presented simultaneously. 
To solve problems directly is the principle of this work. For 
example, a new, quick, and sensitive radiometric assay for glutaminase 
activity was established to eliminate the uncertainty inherent in most 
of the existing assays; a new purification procedure with high yield of 
glutaminase was established to solve the low yield problem. The author 
relizes that there is no single procedure or set of procedures by which 
any and every protein can be isolated. Nevertheless, the author 
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A simple, quick, and sensitive radiometric assay for glutaminase 
has been established. This assay uses h_-(u-14c)-glutamine as the sub-
strate and measures the 14co2 produced when the reaction is coupled to 
glutamate decarboxylase. An efficient purification procedure for cow 
brain glutaminase has also been developed; the yield is 12%. Steps 
include acetone extraction, ammonium sulfate fractionation, calcium 
phosphate gel treatment, and differential gel filtration on Sepharose 
4B. The final preparation has a specific activity of 385 Mmole/min/mg 
and shows a single protein band on polyacrylamide gel electrophoresis 
in sodium dodecyl sulfate; this band corresponds to a subunit molecular 
weight of 82,000. Polyacrylamide gel electrophoresis studies did not 
reveal any impurities; the enzyme activity coincided with the protein 
staining. This enzyme is stable between pH 7.5 and 9.2 and has maximal 
activity around 8.8. The activity of glutaminase appears to be inde-
pendent of the nature of the buffer with which it was equi 1 i brated 
before it was assayed. The enzyme absolutely requires phosphate for 
activity; the dependence is sigmoidal and has a Hill coefficient of 
2.2. The phosphate concentration that gives half maximal velocity is 
50 mM. At 0.2 M potassium phosphate (pH 8.8), the dependence of acti-
vity on glutamine is hyperbolic; the observed Kgln is 17 mM. Neither 
amnonium ion (0.1 M) nor citrate, succinate, or glutarate (57 mM) inhi-
bit the enzyme activity. Glutamate inhibits competitively with respect 
to glutamine. Phosphate affects both K 1 and K 1 the same way. A g n g u 
radioactivity exchange study was not able to detect incorportation of 
14C-glutamate into 14c-glutamine. The results are consistent with a 
model in which arrrnonia is released irreversibly from the enzyme-sub-




Glutaminase (E.C.3.5.1.2., L-glutamine amidohydrolase) catalyzes 
the hydrolytic cleavage of glutamine into glutamate and ammonia. The 
metabolic pathways in Figure l show the importance of this enzyme. 
Glutaminase and glutamine synthetase interconvert glutamine and gluta-
mate; if unregulated, this pair of enzymes will form a futile cycle 
that leads only to the net hydrolysis of ATP. Decarboxylation of glu -
tamate is an irreversible step, catalyzed by glutamate decarboxylase. 
Both glutamate and "Y-ami nobutyrate, the substrate and the product of 
this decarboxyl ase, are important neurotransm ,itters in mamma 1 i an 
brains (1-11). a -Ketoglutarate, one of the metabolites of the tricar-
boxylic acid cycle, is formed from glutamate through a reversible 
reaction catalyzed by glutamate dehydrogenase. 
When 14c-a-ketoglutarate was incubated with a preparation of brain 
mitochondria, very little 14C-glutamate was found (12), suggesting 
that neither glutamate dehydrogenase nor any transaminase catalyzes 
the major pathway for glutamate synthesis. On the other hand, when 
14 . 14 C-glutam,ne was used as a tracer, a large amount of C-glutamate 
accumulated in the brain mitochondria preparation (12), indicating 
that glutaminase is the major enzyme responsible for the synthesis of 
glutamate (13-21, 1). The mechanism of glutamate formation and its 
regulation are not completely understood. In order to study the 
control of glutamate formation, it is necessary to purify glutaminase, 
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Presently, only one purification method is available for brain 
glutaminase (22). The yield for the enzyme from pig brain was less 
than 0.4 % (specific activity= 106 "mole/min/mg) or less than 3% 
(specific activity= 358 nmole/min/mg) when the final preparation was 
dissolved in a Tris buffer or a borate-phosphate buffer, respectively. 
This purification method does not produce large amounts of enzyme. 
To date, including enzymes from all sources, the molecular weight of 
glutaminase is still ambiguous (22-26), and no amino acid composition 
has been published. There are at least two factors contributing to 
the difficulty of glutaminase study. First, glutaminase is a mito-
chondrial membrane associated enzyme (27-39, 22, 12, 13, 24). It is 
very difficult to solublize. Second, all the assays used for gluta-
minase activity determination have limitations, as well be discussed 
later, which impose restrictions upon the purification procedure. 
In order to overcome previous difficulties in enzyme purification 
and to compile useful and reliable data for glutaminase, this work 
attempts to (a) establish a new and effective radiometric assay for 
glutaminase activity, (b) develop a simple and efficient purification 
procedure for cow brain glutaminase, (c) elucidate the mechanism of 
action of the enzyme, and (ct) define some of the characteristics of 
the enzyme. As a consequence of this work, further study of brain 
glutaminase has been greatly simplified. 
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REVIEW OF LITERATURE 
General Background 
Inorganic armnonia is fonned during the catabolism of amino acids 
and is strongly toxic to living cells. · In higher animals, ammonia is 
incorporated into glutamine as an important nontoxic intennediate. 
Glutamine lies at the center of cellular nitrogen metabolism; the 
amide nitrogen serves as the immediate source of nitrogen atoms for a 
wide range of bioche mical substances (Figure 2). In 1904, S. Long 
repor t ed that glutamine is deamidated by a great variety of animal 
tissues (40). 
The presence of glutaminase in animal tissues was first reported 
by H. A. Krebs in 1935 (41). He distinguished between two types of 
this enzyme, the brain type and the liver type. The brain type was 
called glutaminase I, and required phosphate for activity (42-43, 
45-50) . The liver type was called glutaminase II, and was not acti-
vated by phosphate but did require an a-keto acid for activity (42, 
43, 45, 50-53). This enzyme has been identified as a glutamine- a-keto 
acid transaminase (42). A liver enzyme with a nonnal glutaminase 
activity has been reported by W. E. Knox and his colleagues (54-58); 
it requires phosphate for activity. 
Katunuma et al. first reported in 1966 that two glutaminase 
isozymes are found in rat kidney; they have subsequently found them 
in many other animal tissues (59, 60). One isozyme requires phos-
phate for activity (phosphate-dependent glutaminase) while the other 
4 
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Figure 2. Metabolic fates of the amide nitrogen of 1_-glutamine. 
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does not require phosphate but is activated by maleate (phosphate-
independent glutaminase). The phosphate-independent glutaminase has 
been shown to a Y-transpeptidase; maleate promotes glutaminase acti-
vity while blocking transpeptidation (61-63). A mechanism of action 
of transpeptidation as well as a functional role for maleate has been 
proposed recently (64). 
6 
Kidney phosphate-dependent glutaminase appears to be immunolog-
ically (65) and kinetically (66-70) very much like the brain phosphate-
dependent glutaminase. The strongest support for this comes from a 
recent report by Clark and Curthoys (71); they found that the kidney 
glutaminase, immunoprecipitated from Triton X-100-solublized mito-
chondria, is composed primarily of a subunit which has molecular 
weight almost identical with that of the cow brain glutaminase reported 
by Boeker and Chiu (72). Phosphate-dependent glutaminase from kidney 
also showed an immunoprecipitation curve identical with that of the 
phosphate-dependent glutaminase from small intestine (37). However, 
antisera prepared against the rat kidney enzyme did not cross-react 
with glutaminase solubilized from rat liver mitochondria (65). Since 
these two enzymes also exhibit distinct kinetic properties (54, 65), 
the liver enzyme has been recognized as a distinct isozyme (65). 
Escherichia coli contains also two types of glutaminases, A and B 
(73-75) . Glutaminase A possesses maximal activity at about pH 5 and 
is present in stationary phase cells. Glutaminase B occurs in log 
phase cells; like the phosphate-dependent glutaminases of animal 
tissues, this enzyme is active only when phosphate is present and the 
pH is greater than 7. 
Role of Glutaminase 
In brain 
Abundant evidence now exists which suggests that glutamate is one 
of the principle synaptic transmitters in the vertebrate central 
nervous system (1). It strongly excites almost all neurons examined, 
and has been considered to be a main excitatory transmitter. The 
product of glutamate decarboxylation, Y-aminobutyrate, has the oppo-
site effect; it strongly inhibits depolarization of the nerve cell 
membrane (l-9). 
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Glutamine has been shown to be the major precursor of transmitters 
in nerve endings (l, 13). Mammalian cortical synaptosomes incubated 
in the presence of 0.5 mM glutamine and 2.5 mM glucose showed a 30% 
increase in transmitter amino acid content over the control without 
glutamine. Isotope labelling experiments showed that in the presence 
of glucose, the contribution of glutamine to the total glutamate, 
aspartate, and Y-aminobutyrate in the tissue relative to glucose was 
50-70%; to glutamate alone, it contributed 80%. However, in the 
absence of glucose, glutamine alone is not an adequate substrate at 
concentrations up to 0.75 mM; its contribution to energy metabolism 
seems to be minimal. 
Since (a), glutamine can readily pass the blood-brain barrier 
(76), (b), glutaminase activity in the nerve endings is high (31, 77, 
78), and (c), isolated brain mitochondria do not synthesize a sub-
stantial amount of glutamate from a-ketoglutarate (12), glutaminase is 
thought to play a major role in replenishing the pool of glutamate in 
mammalian brain (13, l, 14-21). 
In kidney 
In 1943, Van Slyke found that 60% of the ammonia excreted by the 
kideny was derived from glutamine (79), a fact which has since been 
confinned (80, 81). The remaining carbon skeleton of glutamine, 
a-ketoglutarate, can be used by the kidney for glucose synthesis (82, 
83). It has been suggested that phosphate-dependent glutaminase 
enables kidney mitochondria to respire in the presence of glutamine 
( 32 , 21 , 84) . 
The mammalian kidney increases its ammonia production as part of 
the adaptive response to chronic acidosis (49, 85, 86, 79, 88-92). 
The ammonia is used primarily to titrate acids which are then excreted 
by the kidney (23, 85). It has been found that it is the phosphate-
dependent glutaminase which responds to acidosis as well as to renal 
ammoniagenesis (27, 65, 91-95): (a) The phosphate-dependent gluta-
minase solubilized from nonnal and acidotic rat kidneys are imnunolog-
ically identical and exhibit similar kinetic properties (65). (b) 
The phosphate-dependent glutaminase, but not the phosphate-independent 
enzyme, responds to metabolic acidosis or alkalosis (89, 90, 93). (c) 
The amount of phosphate-dependent glutaminase increases 20-fold 
within the proximal convoluted tubules of the rat nephron (65, 89). 
(d) Actinomycin D prevents elevated ammonia excretion in the acidotic 
rat (88). 
However, in acute acidosis, phosphate-dependent glutaminase does 
not make responsive changes although the synthesis of ammonia, as in 
chronic acidosis, is increased (88, 97). It has been proposed that 
the decreased glutamate concentration in acute acidosis could 
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stimulate ammonia production by reducing the inhibition of glutamate 
on the phosphate-dependent glutaminase (94, 98, 99). 
9 
The control mechanism for adaptation to either chronic or acute 
acidosis has been studied rather extensively. Most of the work focuses 
on (a) a-ketoglutarate, the regulator of the renal mitochondrial glu-
taminase transport system (100), (b) glutamate, the glutaminase inhi-
bitor which decreases during acidosis (101-103, 97, 98, 94), and (c) 
phosphoenolpyruvate carboxykinase, the enzyme which could be the major 
site of metabolic control of gluconeogenesis and ammoniagenesis when 
glutamate or a-ketoglutarate is converted to glucose (82, 83, 95, 104, 
106, 94, 98, 97). So far, none of the studies is conclusive. 
In the small intestine 
The most abundant amino acid in mammalian plasma, glutamine (107), 
is taken up and metabolized by the small intestine of animals (108, 
109} and men (110). This metabolism of glutamine accounts for 30% of 
carbon dioxide produced, relative to glucose (108). 
A highly active phosphate-dependent glutaminase was found in the 
mucosal epithelium of rats, dogs, cats, hamsters, rabbits, and monkeys 
(37); the net uptake of glutamine by intestine was found to be propor-
tional to the blood glutamine concentration and the glutaminase acti-
vity. Based on this and experimental data from inhibition studies 
using glutamine analogs, it has been suggested that phosphate-depend-
ant glutaminase is the major glutamine utilizing enzyme in small 
intestine (37). 
In Hela cells 
When Hela cells were grown exponentially on glutamine and sugar, 
a dramatic phenomenon was observed: the cells used glutamine, not 
sugar, as the major source for energy (111). Less than 2% of the 
glutamine was incorporated directly into protein, 35% of the carbon 
appeared as carbon dioxide, 13% was incorporated into lactate, and 
about 25% into macromolecules. This result occurred regardless of 
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the sugar used, i-~-, fructose, galactose, or glucose, excepting that 
a large amount of glucose and a small amount of glutamine were used as 
the growth medium. This experiemnt also indicated that little sugar 
carbon was oxidized in the tricarboxylic acid cycle, glycolytic acti-
vity was low, and almost all of the carbon arising from fructose was 
metabolized through the pentose phosphate pathway and was not a source 
of energy. 
Follow-up studies to this recent report on glutamine metaboli.sm 
should be very interesting. There seems to be little doubt but what 
glutaminase is responsible for the primary energy producing pathway. 
In tumors 
Phosphate-dependent glutaminase activity has been found to in-
crease in proportion to the growth and the degree of histological 
undifferentiation of various tumors (58, 54-56). A series of experi-
ments on hepatic and nonhepatic rat tumors showed that only gluta-
minase resembling the phosphate-dependent enzyme from kidney or brain 
was increased (58, 55, 56). Even in a series of hepatomas, neoplasms 
originating from liver tissue, only the kidney enzyme, and not the 
liver enzyme, increased. Although the adult liver contains only the 
liver form, the kidney form occurs before birth (54). Thus, liver has 
the potential for both forms of the enzyme. It has been suggested 
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that glutamine hydrolysis may be needed for neoplastic growth, since 
the kidney enzyme, \.,ihi ch has a much 1 ewer Km than the 1 iver enzyme, 
can play a more efficient role. In addition, since the liver enzyme 
is activated in an allosteric manner by glutamine and inhibited by 
adenosine diphosphate (58, 54), enzyme activity, and therefore the 
growth of tumor cells, will be regulated by both the substrate concen-
tration and the energy charge. 
The parenteral administration of enzymes which degrade amino 
acids required only for growth of neoplasms offers a potential cancer 
therapy with marked specificity for the tumor (112-114}. It has been 
shown that asparaginase-resistant Ehrlich carcinomas regressed per-
manently when tumor-bearing mice were injected with bacterial gluta-
minase or glutaminase-asparaginase preparations (115, 116). Therefore, 
glutaminase has been studied as an antineoplastic agent (117]. 
However, all ani mal glutaminases known so far have a very high Km 
(>> 0.1 mM) and also are strongly inhibited by their product; they are 
probably not suitable for antitumor treatment. 
Subcellular location of glutaminase 
Brains of rat (29), pig (22), rabbit (12), chick (31), and toad 
(13), kidneys of rat (27, 28, 30, 32, 39, 33) and pig (24, 34), liver 
of pig (35, 36), skeletal muscle of rat (38}, and mammalian small 
intestines (37) have all been found to contain at least one phosphate-
dependent glutaminase. All these enzyme are mitochondrial. Pig 
kidney phosphate-dependent glutaminase was found to be located exclu-
sively in the mitochondria by Klingman and Handler in 1958 (34); they 
used detergent solublization and sonication. Similar techniques were 
used later to show that the rat kidney enzyme is bound to the inner 
membrane of mitochondria (33, 28) . . 
Glutaminase Assay 
Glutaminase activity has been measured by a variety of methods, 
which include ammonia evolution, ammonia sensitive electrodes, paper 
chromatography, ion exchange column chromatography, and coupling to 
the glutamate dehydrogenase reaction. Every one of these methods has 
significant drawbacks. It seems likely that at least some of the 
confusing and conflicting results for glutaminase are due to tbe 
deficiencies of the assays used. In all cases, the assay used must 
be considered when data are interpreted. 
The ammonia formed by glutaminase has been determined by direct 
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or modified Nesslerization (34, 59, 119, 54, 120-122). Since Nessler's 
reagent is subject to interference by amines, amino acids, proteins, 
inorganic ions, and organic solvents (123), and since precipitation 
occurs frequently after the addition of Nessler's reagent (124), the 
arrrnonia must be distilled or diffused into an acid before measurement. 
During distillation or diffusion, glutamine can be hydrolyzed by the 
strongly basic solution, producing spurious ammonia (125). The 
adapted ammonia diffusion-titration assay described by Mattenheimer 
and Debruin appears to have high reproducibility but low accuracy 
(124). Since the procedure is also tedious and requires skillful 
operation, this assay is not often used. 
Ammonia at concentration higher than 0.1 mM has been measured 
directly with an ammonia electrode (126, 127). This method requires 
at least 3 ml of solution and is subject to interference by potassium 
ions and volatile amines (125, 128-130). It should be noted that, in 
general, assays measuring ammonia require that ammonia be removed 
from the substrate solution before assay. 
In chromatographic assays, glutamate is separated from glutamine 
by paper chromatography, located with ninhydrin, eluted, and measured 
colorimetrically (131-133, 74). This method is inherently imprecise 
and requires an overnight separation on paper. A newer assay sepa-
rates radioactive glutamate by thin-layer chromatography, locates it 
with ninhydrin and then quantifies the glutamate by radioactivity. 
This method is very sensitive and requires only 35 minutes for the 
chromatogram to develop (134}. However, when labelled glutamate is 
heated with ninhydrin, radioactive carbon dioxide is formed and 
escapes into the air, making the assay unreliable. 
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Dowex-1 (Cl) has been used to separate radioactive glutamate from 
glutamine (135, 75). When the pH is higher than 9 both glutamate and 
glutamine are bound to the resin; below pH 6 both compounds are eluted. 
At pH 7, 100% of the glutamate is bound while 90-95% of the glutamine 
is recovered. Since (a) the substrate must be purified before use, 
(b) pyrollidonecarboxylate cannot be separated from glutamate at 
neutral pH, and (c) EDTA, phosphate, chloride, glutamate, and imidazole 
all interfere with the chromatography, this method apparently is un-
suitable for detection of the phosphate-dependent glutaminase. 
The most commonly used assays for glutaminase employ coupling to 
glutamate dehydrogenase to measure either the glutamate or the ammonia 
formed. Detection is based on the absorbance of NAD(P)H at 340 nm. 
Assays in which ammonia is measured (133, 24, 74, 133, 136) are sensi-
tive to contaminating ammonia (24, 131) and ammonia from nonenzymatic 
hydrolysis of glutamine (137, 125, 124). It is known that a-ketoglu-
tarate undergoes dimerization in solution (125). It is known also 
that the presence of a-ketoglutarate, an activator of glutaminase 
under some conditions, interferes with the reaction (24). 
In the coupled assay where glutamate is determined (89, 13), the 
dehydrogenase is not added until after the glutaminase reaction has 
been stopped. This method is direct and is not subject to interfer-
ence by most compounds, but it requires that the dehydrogenase re-
action proceed in the unfavorable direction. Besides, several small 
volumes transfered by pipets, from a fraction of one microliter to 
a few micro liters, are required; the procedure is also tedious. 
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All assays coupled to glutamate dehydrogenase share the following 
drawbacks: (a) Bovine liver glutamate dehydrogenase is inhibited by 
a variety of compounds (138}; ATP and GTP are powerful inhibitors (139, 
140), while ADP is an activator, in the direction of glutamate syn-
thesis (141). (b) Since the phosphate-dependent glutaminase has a pH 
optimum around 8.8, the assays must be run at a suboptimal pH to 
accomodate the glutamate dehydrogenase action. (c) The assays are 
limited by the absorbance of NAD(P)H. 
Recently Chiu and Boeker have reported a new radiometric assay 
for phosphate-dependent glutaminase (66). The assay is stopped by 
reducing the pH to 4.5, where glutaminase is completely inactive. 
f. coli glutamate decarboxylase is then added to release all of the 
a-carboxyl group from radioactive glutamate. The 14co2 is then 
trapped and counted. Regardless of the conditions used, the only 
requirement for an accurate assay is that enough glutamate decar-
boxylase be added to convert all the glutamate to carbon dioxide. 
As will be discussed in detail later, this assay is simple, quick, 
inexpensive, and practical for handling a large number of samples. 
The principle limitation of this assay is that it does not measure 
enzyme activity continuously. 
Properties of Glutaminase 
Purification 
15 
Progress in the study of phosphate-dependent glutaminase has been 
very slo1~ because of the difficulties encountered in extracting and 
stabilizing this enzyme. The pig kidney enzyme was first solubilized 
by Otey, Birnbaum, and Greenstein in 1954 (142). Klingman and Handler 
purified it 200-fold in 1957, by making a mitochondrial extract in 
borate buffer and chromatographing it on Amberlite XE-97 (34). The 
same report indicates that numerous attempts at purification, in-
cluding heat treatment, isoelectric precipitation, protamine precipi-
tation of nucleic acids, fractionation with metals, amnonium sulfate 
or ethanol fractionation, absorption and elution from calcium phos-
phate, calcium borate, alumina Cy gel, Dowex-1 chloride or borate, 
Dowex-50, Amberlite IRC-4B, IR-400, or XE-64, hydroxyapatite or Celite 
columns, electrophoresis on potato starch blocks, sodium dodecyl 
sulfate, digitonin, or deoxycholate treatment, or sonication did not 
produce satisfactory purification. A year later, Sayre and Roberts 
obtained the same purification factor by repeated sodium sulfate 
fractionation of dog kidney homogenate which had been kept frozen for 
several weeks (119). 
The first homogeneous phosphate-dependent glutaminase preparation, 
isolated from pig kidney, was reported by Kvamme, Tveit, and Svenneby, 
16 
in 1970 (24, 132). The main steps of this procedure consisted of 
sodium sulfate fractionation and alternative solubilization, by 
dialysis against Tris-HCl buffer, and precipitation with phosphate-
borate buffer. This 10,000-fold purification is based on the fact 
that the enzyme aggregates in phosphate-borate buffer and disaggre-
gates in Tris-HCl buffer. The final preparation, in phosphate-borate 
buffer, had a specific activity of 320 ~mole/min/mg; the yield was 3%. 
In Tris-HCl buffer, electrophoresis on polyacrylamide gel gave one 
protein band but no activity could be recovered. Sedimentation 
velocity studies revealed one symmetrical peak, and the irrrrnune diffu-
sion technique did not detect any impurity. In a later report (26), 
the same enzyme preparation showed two protein bands after polyacryl-
amide gel electrophoresis in sodium dodecyl sulfate. 
The pig brain enzyme was purified 5,000-fold by G. Svenneby in 
1970 (131) and then 10,000-fold by Svenneby, Torgner, and Kvamme in 
1973 (22). The main steps were acetone extraction, sodium sulfate 
fractionation, and alternative solubilization and precipitation in 
Tris-HCl buffer and phosphate-borate buffer. Isoelectric focusing 
and sedimentation equilibrium studies revealed no impurities. With 
polyacrylamide gel electrophoresis, one protein band was detected 
on reqular gel, and one major and one minor band in the presence of 
sodium dodecyl sulfate. The yield of enzyme was 2.8 %. The specific 
activity was 358 Mmole/min/mg when the enzyme was dissolved in phos-
phate-borate buffer. 
The rat kidney enzyme was purified by Curthoys, Kuhlenschmidt, 
and Godfrey in 1976 with 11% recovery (25). The final preparation 
had a specific activity of 320 µmole/min/mg. The steps were 
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mitochondrial preparation, digitonin treatment, lyophilization, 
ammonium sulfate precipitation, and successive gel filtrations. Poly-
acrylamide gel electrophoresis showed a broad protein band; the enzyme 
activity recovered from a sliced gel was consistent with the protein 
band. This is the only report where highly purified glutaminase 
activity has been recovered from a gel. However, this enzyme would 
not enter the gel unless 0. 1% Triton X-100 was present. Polyacryl-
amide gel electrophoresis in sodium dodecyl sulfate revealed at least 
five protein bands (143); further studies suggest that the hetero-
geneity results from a partial proteolysis which does not inactivate 
the enzyme (71, 23,143). 
Glutaminase B from E. coli is the only other phosphate-dependent 
glutaminase which has been purified more than l ,000-fold. Purifi-
cation steps were streptomycin precipitation, ammonium sulfate frac-
tionation, DEAE chromatographies, Agarose 1.5m filtration, and prepa-
rative electrophoresis. The final preparation had a specific activity 
of 716 ~mole/min/mg and the yield was 19%. Estimation by contiunous 
electrophoresis on polyacrylamide gel suggests that the enzyme was 40% 
pure (75). 
It should be noted that almost every report used its own assay 
method and that the concentrations of phosphate and substrate in the 
assay solutions were by no means consistent. This may account for 
some of the apparent variability observed for glutaminase. 
Molecular weight 
Molecular weight estimations for phosphate-dependent glutaminase 
are very inconsistent so far. There is not one purified enzyme that 
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has been studied by two independent methods with consistent results. 
It seems likely either that the enzyme is not completely pure, or that 
partial proteolysis has occurred (71), or both. 
In general, in Tris buffer, glutaminase is in its lowest mole-
cular form, the so-called Tris form. (24, 22, 26, 131, 144, 25, 72). 
Phosphate induces aggregation, perhaps through dimerization (144). 
Phosphate and borate together induce further aggregation to a form 
with molecular weight higher than one million (24). This reversible 
aggregation has been observed in studies of sedimentation (24, 22, 
144), Sephadex G-200 (25), Sepharose 4B (25, 72), and electron micro-
scopy (26, 145, 132). In this section, only the lowest molecular 
form will be discussed. 
Assuming a partial specific volume of 0.732 ml/g for the pig 
kidney enzyme, the estimated molecular weight by sedimentation equili-
brium in 10% sucrose is 170,000 (26). The value estimated from 
Sephadex G-200 gel filtration and sucrose gradient centrifugation is 
140,000-160,000 (24). From electron microscopy, the molecular weight 
is calculated to be 125,500 if the shape is prolate-ellipsoidal and 
187,000 if the shape is cylindrical (26). Polyacrylamide gel electro-
phoresis in sodium dodecyl sulfate reveals two close bands, corre-
sponding to subunit molecular weight of 53,000 and 61,000 (26). It 
has been suggested that the molecule may be a trimer, a2B or B2 a , 
although this contradicts the electron microscopic observations. 
The pig brain enzyme has been studied by sedimentation equili-
brium. Earlier work on a partially purified preparation found a mole-
cular weight of 117,000 (146), whereas recent work gave a value of 
187,000 for a highly purified preparation (22). By polyacrylamide gel 
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in sodium dodecyl sulfate, only one protein staining band with a mole-
cular weight of 64,000 was found (22). The idea that pig brain enzyme 
is a trimer has also been suggested. 
Rat kidney glutaminase eluted from a calibrated Sephadex G-200 
colurnn with an apparent molecular weight of 190,000, whereas sucrose 
gradient centrifugation suggests 115,000 (25) . In a careful experi-
ment, using techniques similar to these, the molecular weight was 
redetermined to be 160,000 (144). Upon sodium dodecyl sulfate poly-
acrylamide gel electrophoresis, the highly purified enzyme exhibited 
at least five protein staining bands with molecular weights ranging 
from 57,000 to 75,000 (143). L-2-amino-4-oxo-5-chloropentanoic acid, 
an analogue of glutamine, has been found to react with each of the 
protein staining bands (143). Recently, a follow-up report showed 
that all of these bands are related in structure and that glutaminase, 
immunoprecipitated from Triton X-100 solubilized mitochondria, is 
composed primarily of subunits which have molecular weight of 83,000 
(71 ). This value is consistent with the value for cow brain gluta -
mi nase reported earlier by Beeker and Chiu (72). All of the results 
taken together strongly suggest that the heterogenity in subunit size 
results from partial proteolysis and that the molecule is a dimer. 
The molecular weight of glutaminase B from I_. coli has been esti-
mated to be 90,000 by Sephadex G-200 gel filtration and analytical 
polyacrylamide gel electrophoresis (75). Since the enzyme was only 
about 40% purified, further investigation is necessary. · 
pH optimum and Km 
The activity of glutaminase as a function of pH has been studied 
in many tissues with several assays. The tissues include pig brain 
(131) and kidney (132, 24), rat brain (48) and kidney (59, 34, 60, 
147, 25, 39), dog kidney (119, 124), human kidney (124), and rat 
intestine (37). Since different assays were used, the results are 
not entirely comparable. However, two conclusions can be drawn. The 
pH optimum lies between 8 and 9 and enzyme is inactive below 6 or 
above 11. In addition, the optimal curve is broader when borate is 
present. 
The value of Km for glutaminase has been reported to decrease 
with increasing phosphate concentration (149, 119, 132), increase 
with increasing pH (68), and increase with increasing borate concen-
tration (132). The measurement of Km is also sensitive to the purity 
of enzyme and the assay method. Each determination of Km should be 
recognized as a result of a particular assay method and set of 
conditions. 
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The Km measurements for pig brain glutaminase have been inter-
preted in a very complicated manner. The value for the enzyme equili-
brated in Tris-HCl buffer increases from 5 mM to 20 mM when the pH is 
increased from 6.5 to 10 (68). Corresponding values for the enzyme in 
phosphate-borate buffer are 1.8 and 8 mM. The plots of velocity 
versus glutamine were all sigmoidal, and phosphate concentration up to 
300 mM did not cancel the sigmoidal pattern. Decreasing pH lowered 
the enzyme activity and shifted the pattern from sigmoidal to hyper-
bolic. It has been suggested that the enzyme is allosteric and that 
protons may play a role as effectors. In trying to explain the sig-
moidal pattern, speculations included the induced fit theory, substrate 
cooperativity, ligand exclusion theory, and one catalytic site theory. 
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It was concluded that all theories were possible (68). It should be 
pointed out that this experiment did not use substrate concentrations 
higher than 20 mM, the Km was detennined with four data points, par-
tially purified enzyme was used, and the enzyme activity was deter-
mined by paper chromatography in 300 mM potassium phosphate. A 
follow-up report found the Km to be in _the range of 5 rnM to 9 mM (150). 
The rat brain enzyme has been reported to have a Km of 30-50 mM, using 
Nesslerization in 0.2 M potassium phosphate at pH 8.6 (60). Another 
report on rat brain enzyme shows Km values of 16 mM and 11 mM when it 
was assayed in phosphate concentrations of 5-30 rnM and 100 mM, respec-
tively (149). The Km of the pig kidney enzyme has been found to be 
4.3 mM and 5.8 mM in Tris-HCl buffer and phosphate buffer, respec-
tively (132). The assay was spectrophotometric, employing coupling 
to glutamate dehydrogenase to determine the fonnation of ammonia in 
0. l M sodium phosphate at pH 8. It was found that the Km decreased 
when the phosphate concentration was increased (67). An earlier 
report found a Km of 5 nt~ for the pig kidney enzyme with Nessleri-
zation (34). Dog kidney glutaminase has a Km of about 5 mM when 
assayed in 0. l M sodium phosphate; the value decreases with the in-
crease of phosphate concentration from 50 mM to 150 mM (119). The rat 
kidney enzyme was found to have a Km of 40 mM when assayed in 0.2 M 
potassium phosphate at pH 8.6 with Nesslerization (60, 59). A Km of 
4-10 mM has also been reported for the rat kidney enzyme, regardless 
of the buffer the enzyme is equilibrated with (89, 25). Here the 
enzyme activity was detected by using glutamate dehydrogenase to 
measure the formation cf glutamate in 150 mM phosphate at pH 8. 6; 
the Km increased with increasing phospha.te concentration. One of two 
other reports on rat kidney glutaminase found the Km to be 21 mM at 
5-30 mM phosphate and 10 mM at 100 mM phosphate (149); the other 
report gave 5 mM in 0.4 M phosphate (34). 
22 
For the enzyme from rat small intestine, Km was found to be 2.2 rw1 
(37). The rat liver enzyme is reported to have Km values of 28 m"'l 
and 80-100 rrt,1 (60,151); the discrepancy apparently arises from the 
assay method and conditions. 
Activation and inhibition 
Glutaminase requires phosphate or a phosphate-containing compound 
for activity. Reports stating that glutaminase shows minor activity 
in the absence of phosphate are probably in error. This is probably 
due to contamination of the preparation by phosphate-independent glu-
taminase or by phosphate itself. 
The pig brain enzyme has a K0_5 for phosphate of 13.5 mM and 69 mM 
when equilibrated with Tris-HCl buffer or phosphate-borate buffer, 
respectively (68). The Hill coefficient is 1.8 regardless of the 
buffer (68). However, these K0_5 for phosphate values may not be very 
accurate; the enzyme was not highly purified and showed some activity 
at zero phosphate concentration. The rat brain enzyme has been re-




for phosphate of 100 mM; the assay mixture con-
tained only 5 mM glutamine, a very low concentration (44). Another 
report shows a K
0
_5 for phosphate of 600 mM when the rat brain enzyme 





for phosphate for the pig kidney enzyme has been shown 
to be 25 mM (87) and 50 mM (132), with Hill coefficients of l.78 and 
1.04, when equilibrated in Tris-HCl and phosphate buffer, respectively 
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(132). An earlier report showed a K0_5 for phosphate of 50 mM regard-
less of the buffer (34). 
The rat kidney enzyme has a K0_5 for phosphate of 35 mM (89). 
The effects of phosphate on sedimentation coefficient and activity 
are consistent and can be used to calculate a K0 _5 for phosphate of 
40-50 mM ( 144). 
The small intestine enzyme from the rat has a K0_5 for phosphate 
of 22 mM. Unlike all enzymes previously described in this section, 
the plot of activity versus phosphate concentration for this enzyme is 
hyperbolic rather than sigmoidal (37). 
Electron microscopic study of the pig kidney enzyme suggests that 
phosphate causes dimerization of the lowest molecular weight form, or 
Tris form (26). Sucrose gradient sedimentation and glutaminase acti-
vity studies of the rat kidney enzyme demonstrated that increasing 
phosphate concentration increases both the sedimentation coefficient 
and the activity of the Tris form the same way, suggesting that there 
is a correlation between dimer formation and activation (144). Z. 
Kovacevic suggested that the binding site of glutaminase for phosphate 
is embedded in the mitochondrial membrane and the binding site for the 
substrate is exposed toward to matrix space (96). The influx of phos-
phate across the mitochondrial membrane may bring about the associ-
ation of inactive Tris form and, therefore, activate the enzyme. 
Reports on the effects of ammonia and carboxylic acids on phos-
phate-dependent glutaminase are contradictory, This probably origi-
nates in the assays used. In the presence of effectors the assay 
situation is very complex, since the effector may affect both 
glutaminase and the coupling enzyme, as well as the sensitivity of 
measurement. 
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Some reports show that ammonia is competitive inhibitor of the 
dog (119) and pig (34) kidney enzymes whereas other reports show that 
ammonia activates the pig kidney (24, 132) and pig brain (68) enzymes. 
Physiologically important carboxylic acids such as pyruvate, 
succinate, malate, malonate, oxaolacetate, a-ketoglutarate, acetate, 
and citrate have been found both to activate (39, 132, 150, 149, 104, 
68, 25, 59, 37) and inhibit (90) glutaminase. It has been suggested 
that, in the absence of phosphate, there is a correlation between 
activation and the number of carboxyl groups per molecule (149, 68). 
L-2-amino-4-oxo-chloropentanoic acid, a chloroketone, and 6-diazo-
5-oxo-L-norl euci ne ( DON) have been show'n to specifically and i rrevers-
i b ly inhibit the glutamine dependent enzyme activity by covalent 
binding at the glutamine (105, 37, 148, 69, 152) or glutamate (10, 
143) binding sites. These analogues have been used to identify the 
glutamine binding peptides in sodium dodecyl sulfate polyacrylamide 
gels (143) and to study the binding of glutamine and glutamate to 
phosphate-dependent glutaminase (23, 143). It has been suggested that 
DON and the chloroketone act on rat kidney enzyme at the binding sites 
for glutamine and glutamate, respectively (23). This suggestion is 
based on the fact that incubation of the enzyme with DON prevents 
binding of the chloroketone only slightly. However, it should be 
noted that the enzyme preparation is heterogeneous, the Tris in the 
enzyme buffer may prevent the binding of DON to the enzyme, and that 
DON does protect up to 30% of the enzyme. A study on the rat small 
intestine enzyme shows that glutamine protects against inactivation 
by both DON and ch l oroketone ~ vivo as well as ~ vitro ( 37). This 
study indicates that both DON and chloroketone are acting upon the 
same site, presumably the glutamine binding site. 
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In the absence of phosphate, glutaminase can be activated by 
phosphate containing compounds such as acetyl-CoA (70), fatty Acyl-CoA 
derivatives (70), riboflavin-5-P (44), and tri- and diphosphate 
nucleotides (44, 149). Acetyl-CoA was reported to have a Ka of 0.2 mM 
(70); its activation is accompanied by an increase in the sedimen-
tation coefficient. Fatty acyl-CoA derivatives are more effective 
activators when the fatty acyl group is unsaturated; they are more 
effective inhibitors when the fatty acyl chain is elongated (70). It 
has been speculated that acetyl-CoA and fatty acyl-CoA derivatives 
might regulate the glutaminase activity~ vivo (70). Tri- and di-
phosphate nucleotides were reported to activate the rat brain enzyme 
more strongly than phosphate itself on the basis of phosphate equiva-
lents (44). On the contrary, the rat kidney enzyme was no more acti-
vated by tri- or diphosphate nucleotides than by phosphate itself (25). 
Studies on the rat kidney and brain enzymes suggest that GTP-cGMP or 
ATP-cAMP might regulate glutaminase; GTP (or ATP) activates the enzyme 
and cGMP (or cAMP) inhibits it (149). Glutaminase B from E. coli 
shows the opposite regulation; ATP and ADP inhibit the enzyme whereas 
AMP activates it (153). 
In 1935 H. A. Krebs reported that the brain type glutaminase was 
strongly inhibited by glutamate (41). It was then reported in 1958 
that glutamate inhibited both the pig kidney (34) and dog kidney (119) 
enzymes noncompetitively. Since then inhibition by glutamate has been 
reported for the pig kidney (87, 67, 132), pig brain (68), and rat 
kidney (60, 23, 144) enzymes; j_.~., almost all phosphate-dependent 
glutaminases studied. Studies on the pig kidney enzyme showed that 
changing the phosphate concentration in the assay mixture from 50 mM 
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to 150 mM could shift the inhibition pattern from noncompetitive to 
competitive (67). Generally, it appears that the enzyme is more sensi-
tive to glutamate inhibition when it is equilibrated with Tris buffer 
than it is in phosphate-borate buffer (87, 68). In both the dog 
kidney (119) and pig kidney (87) enzymes glutamate was found to compete 
with phosphate; however, the same study group also observed noncompet-
itive inhibition (67, 132). 
Glutaminase B from f. coli behaves uniquely toward glutamate. 
Incubation of the enzyme with 20 mM glutamate at 4 C causes a 2-fold 
activation, while addition of 20 mM glutamate to the assay mixture 
results in a 10% inhibition of the enzyme activity (104). It has been 
suggested that gl utami nase B may have two binding sites for glutamate, 
and that activation by glutamate may occur slowly at an allosteric 
site. 
Mechanism of action 
Klingman and Handler proposed a mechanism of action for pig 
kidney glutaminase (34) in which ammonia is released first, reversibly, 
and glutamate is released second, irreversibly. This mechanism is 
based on the following findings: (a) Ammonia acts as a competitive 
inhibitor. (b) Glutamate acts as a noncompetitive inhibitor. (c) 
The enzyme did not catalyze the exchange of 14c-glutamate into 14c-
glutamine but did cause incorporation of 15NH3 into glutamine. 
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Based on a series of kinetic studies, Tveit, Svenneby, and Kvamme 
proposed dead-end complex models for the mechanism of action of kidney 
glutaminase (67, 132). Both models assume that the reaction sequence 
is ordered and that glutamate is the first product to be released. One 
of the models proposes that glutamate binds with free enzyme, thus 
forming a dead-end complex. The other model proposes that glutamate 
binds the enzyme only when phosphate is also bound, and that phosphate 
binds only the free enzyme. They conclude that the dead-end complex 
models can not be considered to be fully established but that other, 




Fresh cow brains were obtained from the E. A. Miller & Son Packing 
Co., Hyrum, Utah. Sepharose 48 was purchased from Pharmacia. Ultra-
filtration cells and XM300 membrane were products of Amicon Co. L-
(u-14c)-glutamine and !:_-(u-14c)-glutamic acid were obtained from New 
England Nuclear. 2,5-Diphenyloxazole, scintillation grade, was from 
Amersham/Searle. Glutamate decarboxylase, a crude acetone powder from 
Escherichia coli, type I, was obtained from Sigma Chemical Co .. 
Calcium phosphate gel was prepared according to the method of Keilin 
and Hartree (154). The gel was washed at least three times with ten 
volumes of distilled water before use. Arginine decarboxylase was a 
generous gift from Dr. E. A. Boeker. The other reagents were analyt-
ical grade. 
Glutamate Decarboxylase 
One gram of acetone powder from~- coli was suspended in 10 ml 
of 0.1 M potassium phosphate, 1 mM dithiothreitol, and l mM pyridoxal 
phosphate (pH 4.2), homogenized in a Potter-Elvehjem homogenizer with 
a teflon pestle, and then centrifuged at 10,000g for 10 minutes at 
0 C. The supernatant was collected and used directly for most assays. 
For kinetic study and/or for precise measurements, the above super-
natant was subjected to further purification. Two grams of anmonium 
sulfate were added to the supernatant; the precipitate obtained by 
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centrifugation at 10,000g for 10 minutes at O C was discarded. One 
gram of ammonium sulfate was added to the resulting supernatant and 
another centrifugation was performed, at 30,000g for 30 minutes at O C. 
The precipitate was dissolved in 5 ml of O.l M potassium phosphate, 
l mM dithiothreitol, and l mM pyridoxal phosphate (pH 4.2). The final 
preparation had a glutamate decarboxylase activity of 50 lJTTiole/min/mg 
and showed no detectable gl utami nase activity for up to two hours 
under standard assay conditions. 
For glutamate decarboxylase assay, 200 ~l of substrate solution 
containing 20 mM !:_-(u-14c)-glutamate (2.7 x 105 CPM) in 0.2 M pyri-
dine-HCl (pH 4.5) was added with 100 ~l of enzyme solution. After 10 
minutes incubation at 38 C, the reaction was stopped by adding 25 ~l 
of 100% trichloroacetate. The mixture was incubated for an additional 
20 minutes, in order to transfer all the 14co2 evolved to the trapping 
solution. The technique of 14co2 trapping and counting is identical 
with that of glutaminase assay, which will be described in detail in 
the next section. Unless otherwise indicated, the enzyme had a spe-
cific activity of 4 ~mole/min/mg\ 37 ~g of enzyme was used per assay, 
and the effective specific activity of the carboxyl group of the sub-
strate vtas 5830 CPM/,umole, taking into account the assay effeciency. 
Glutaminase Assays 
200 ,ul of a solution containing 0.2 M .!:_-(u-14c)-glutamine 
(170,000 CPM) in 0.2 M potassium phosphate buffer (pH 8.8) was added 
to a stoppered 13 x 85 mm test tube and equilibrated at 38 C for five 
minutes. The reaction was begun by adding glutaminase in 100 ~l of 
0.2 M potassium phosphate (pH 8.8). After 10 minutes, the reaction 
was stopped by adding enough 0.4 M pyridine-HCl (pH 1.2) to change 
the pH of the final mixture to pH 4.5 ± 0.2. A 10 x 35 mn piece of 
pleated filter paper was soaked with 25 ~l of a solution of 2-amino-
ethanol 2-methoxylethanol = l : 2 and inserted in the upper part of 
the tube. 100 nl of a glutamate decarboxylase preparation containing 
an activity of at least 20 .umole/min/ml was added to the mixture to 
release all the a-carboxyl groups of glutamate as carbon dioxide. 
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The test tube was immediately recapped with a rubber stopper. After 
30 minutes, the filter paper was transfered to a vial containing 10 ml 
of scintillant (6 grams 2,5-diphenyloxazole, 514 ml Triton X-100, 
212 ml absolute ethanol, 74 ml 2-methoxyethanol, 1200 ml xylene, and 
200 ml distilled water) and counted in a Beckman CPM 100 scintillation 
counter. The assay was standardized by adding sufficient enzyme, 
first glutaminase and then glutamate decarboxylase, to exhaust the 
substrate. The effective specific activity for glutamine was calcu-
lated from the exhaustion value and the amount of glutamine used; it 
normally was about 70%. l~hen less than one-third of the substrate 
was reacted, the assay was linear with time up to 5 hours and with 
protein concentration up to 50 mg/ml. For kinetic studies, less than 
5% of the substrate was reacted in most cases; the detected velocities 
should, therefore, approach initial velocities. 
Most samples were either assayed directly or diluted with the 
sample buffer if needed; unless otherwise specified, no effort has 
been made to standardize the phosphate concentration and the pH of 
samples before they were assayed. Control assays were done either 
by replacing the enzyme solution with buffer or by stopping the re-
action with pyridine-HCl solution before the enzyme was added; either 
way, the results were the same. The experimental data were the 
detected values minus the control. 
Protein Determinations 
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Protein concentrations were determined according to the Coomassie 
blue dye-binding method of Bradford (155) with some modifications. 
A solution of 200 mg Coomassie brilliant blue G, 100 ml of 95% ethanol, 
and 200 ml of 85% (w/v) phosphoric acid was stored in a refrigerator 
at 5 Casa stock solution. For an assay, one volume of stock solu-
tion was diluted with seven volumes of distilled water, then 2.5 ml 
were pipetted into a 12 x 100 mm test tube. Ti.-10 minutes after the 
addition of 100 ~, sample solution, the absorbance at 595 nm was 
measured with a Bausch & Lomb spectrophotometer. Bovine serum albumin 
was used to make a standard curve; the standard curve was linear from 
2 .ug to 20 .ug. 
Paper Chromatography 
Samples were applied to a 2 x 45 cm strip of Whatman #1 paper, 
and chromatographed downward for four hours in water saturated phenol 
containing 0.04 % 8-hydroxyquinoline (156). After air drying, the 
strips were either stained with ninhydrin in 95% ethanol or were cut 
into 1/4 inch sections and transfered to 10 ml scintillant and counted. 
In one experiment, for the study of reversibility of the glutaminase 
reaction, 0.3 ml of a solution containing 27 mM !:._-(u-14c)-glutamic 
acid and 67 mM ammonium ion in 0.2 M phosphate buffer (pH 8.8) was 
incubated at 38 C either in the absence or presence of glutaminase 
at a concentration of 0.56 ~mole/min/ml. After 10 hours, 0.4 ml of 
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0.4 M pyridine-HCl {pH 1.2) and 0. l ml of 0.2 M glutamine were added, 
and 50 ~, aliquots containing 18,000 CPM were chromatographed and 
counted as described above. In the other experiment, 0.4 ml of a solu-
tion containing 20 mM !:._-(u-14c)-glutamic acid, 50 mM arrrnonium ion and 
50 mM glutamine in 0.2 M phosphate buffer (pH 8.8) was incubated over-
night at 38 C either in the absence or presence of glutaminase at a 
concentration of 0.42 ~mole/min/ml; 50 ~, aliquots containing 33,000 
CPM were chromatographed and counted as before. 
Gel Electrophoresises 
Polyacrylamide gel electrophoresis was performed according to 
Davis et al. (157). Samples containing 20% sucrose were run on 7.5% 
polyacrylamide gels at 3 mA/gel. For subunit molecular weight estima-
tion, glutaminase was preheated at 70 C for 20 minutes in the presence 
of 1% sodium dodecyl sulfate, 1% mercaptoethanol, 10% glycerol, and 
10 mM sodium phosphate {pH 7.2), and then run on 7.5% polyacrylamide 
gel in 0.1 % sodium dodecyl sulfate at 8 mA/gel. In all cases, 0.002% 
bromophenol blue was used as a marker; gels were stained in a solution 
of 0. 25% Coomassie blue in methanol : acetic acid : water= 5 : 1 : 5 
for one hour and destained in a solution of 7.5% acetic acid and 5% 
methanol. 
Glutaminase Purification Procedure 
Acetone extractions 
Fresh cow brains were chilled in ice. The cerebellum, outer 
membrane, and as much white matter as possible were removed, and the 
brains were stored at -20 C overnight or longer. The frozen brains 
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were cut into small pieces and homogenized five minutes in five 
volumes of -80 C acetone in a Sorvall Omni-mixer at speed five. This 
and all succeeding steps were carried out in a well-ventilated cold 
room at 4 C. The homogenized suspension was filtered on a Buchner 
funnel using Whatman #l filter paper. The filter cake was rehomo-
genized in acetone and then filtered again. A wet weight of 100 grams 
brain produced about 12 grams of light pink acetone powder. The 
acetone powder has been stored at -20 C for more than a year without 
loss of activity. 
Ammonium sulfate fractionation 
Two hundreds grams of acetone powder was suspended in 4 liters of 
20 mM sodium borate and 2 mM EDTA (pH 8.6), homogenized at 240 rpm in 
a Potter-Elvehjem homogenizer with a teflon pestle, and centrifuged 
at 16,000g for 20 minutes at O C. Unless otherwise indicated, all 
centrifugation conditions were the same as these. Solid MgCl2·6H2o 
was added with stirring to make the solution 20 mM in Mg++; then 0.5 
gram protamine sulfate was added. One hour later, 265 grams solid 
ammonium sulfate was added slowly with stirring. The suspension was 
centrifuged. 
Another 400 grams solid ammonium sulfate was added to the result-
ing supernatant and a centrifugation performed. The precipitate was 
suspended in 94 ml of 20 mM sodium borate and 2 mM EDTA (pH 8.6); the 
resulting suspension had a specific acivity of about 1.5 Nmole/min/mg. 
Calcium phosphate gel treatment 
One hundred grams of calcium phosphate gel (wet weight) were added 
to the above suspension which was then centrifuged at 5,000g for 10 
34 
minutes at 0 C. The supernatant was discarded and the gel was washed 
with 100 ml of 20 mM sodium borate and 2 mM EDTA (pH 8.6); the super-
natant was again discarded. The glutaminase was washed off the gel 
using 260 ml of 100 mM potassium phosphate, 100 mM sodium pyrophos-
phate, and 10 mM sodium borate (pH 8.8). The supernatant was then 
concentrated to 25 ml in an Amicon ultrafiltration cell using a Diaflo 
XM300 membrane. 
Sepharose 4B columns 
The concentrated solution was dialyzed in four steps against four 
liters of 100 mM potassium phosphate, 100 mM sodium pyrophosphate, 
and 10 mM sodium borate (pH 8.8), four hours for each step. After 
insoluble material was removed by centrifugation, the sample was loaded 
on the top of a 4.2 x 60 cm Sepharose 4B column equilibrated with 
100 mM potassium phosphate, 100 mM sodium pyrophosphate, and 10 mM 
sodium borate (pH 8.8). The column was eluted with the same buffer. 
Glutaminase activity appeared slightly after the void volume. Frac-
tions with specific activity higher than 4 ~mole/min/mg were pooled 
and concentrated to 13 ml in an Amicon ultrafiltration cell as before. 
After dialysis in four steps against four liters of 10 mM Tris-HCl, 
100 mM sodium pyrophosphate, and 0.2 mM dithiothreitol (pH 8.8), the 
insoluble material was removed by centrifugation. The sample was 
loaded on the top of a 2.6 x 100 cm Sepharose 4B column equilibrated 
with 10 mM Tris-HCl, 100 mM sodium pyrophosphate, and 0.2 mM dithio-
threitol (pH 8.8). The column was eluted with the same buffer. Active 
fractions eluted in about two and one half times the void volume. 
Appropriate fractions were pooled. 
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pH Activity and Stability 
For the pH-activity profile, glutaminase was prepared by dialyzing 
against 0. l M potassium phosphate (pH 8.8), or 10 mM Tris-HCl and 0.2 rrM 
EDTA (pH 8.8), or 10 mM sodium borate, 0.1 M potassium phosphate, and 
0. l M sodium pyrophosphate (pH 8.8) before assay. The substrate solu-
tions were made from different combinations of two solutions, one con-
taining 0.2 M K3Po4 and 0.2 M glutamine and the other containing 0.2 M 
KH2Po4 and 0.2 M glutamine. All assays were done according to the 
standard method. 
The stability experiment was completed with the standard assay 
except that glutaminase was incubated at the indicated pH for 5 hours 
at 38 C before the assay. To do this, glutaminase in 100 ~, of 0.2 M 
potassium phosphate buffers (pH 8.8) was added with different volumes 
of either 0.2 M K3Po4 or 0.2 M KH2Po4 to shift the pH. At the end of 
the incubation, the pH was brought back to 8.8 with appropriate volumes 
of the alternate potassium phosphate solution, all to a final volume of 
491 Ml, 100 Ml of each final enzyme solution was then used for the 
assay. 
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RESULTS AND DISCUSSION 
Glutaminase Assay 
Figure 3 shows that the assay for glutamate decarboxylase activity 
was linear with time and protein concentration when less than one half 
of the substrate was reacted. Figure 4 shows that neither glutamine, 
aspartate, nor Y-aminobutyrate interfere with the decarboxylation assay 
up to concentrations of 20 mM, 4 mM, and 20 rrM, respectively. a-Keto-
glutarate inhibits glutamate decarboxylase competitively; this inhi-
bition can be released by increasing the glutamate (data not shown). 
Glutamate decarboxylase was used to release the a-carboxyl group 
of glutamate, the product of glutaminase action on glutamine. The 
specificity of this enzyme has been studied extensively (158-165, 118). 
However, there is no qlutamate decarboxylase free from glutaminase 
activity commercially available so far. A simple partial purification 
of glutamate decarboxylase was developed for this dissertation, starting 
with commerically available acetone powder of I_. coli. This contains 
both glutaminase A and glutaminase B (73-75). Since glutaminase A is 
active at pH 4.5, it will interfere with the glutaminase activity 
measurement. Therefore, the effect of glutaminase A on the radiometr ·ic 
assay was carefully investigated. The results in Table 1 show that (a) 
glutamate decarboxylase does not use glutamine as a substrate, (b) glu-
tamate decarboxylase is contaminated with a glutaminase which is active 















10 20 30 40 50 
Time, minute (*) 
0 35 70 105 140 175 
Protein, JJg (e) 
Figure 3. Glutamate decarboxylase activity at varying time or 
protein concentration. The assay method was described under "EXPERI-
MENT.A.L PROCEDURES," excepting that the assay time or the protein con-
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Figure 4. The effects of free amino acids on glutamate decarboxylase activity. Standard method 
for glutamate decarboxylase assay described under ''EXPERIMENTAL PROCEDURES" was used, excepting that 
the substrate solution contains free amino acid as indicated, glutamine (• ); Y-aminobutyrate (-¢-); 
asparatate (•); a -ketoglutarate (•). Each point represents the average of three tests. 21 J.Jg of 
glutamate decarboxylase was used for each assay. 
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aThe assay was described in 11EXPERIMENTAL PROCEDURES." Substrate 
exhaustion gave 18,500 CPM. 
bpartial purification of glutamate decarboxylase was described in 
11EXPERIMENTAL PROCEDURES.11 Both unpurified and partially purified 
glutamate decarboxylase had an activity of 15 umole/min/ml. 
crncubation time was the time between the addition of glutamate 
decarboxylase and the removal of filter paper. 
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Since less than 5% of the glutamine present was allowed to react 
in most kinetic assays and since it was impossible to obtain glutamate 
decayboxylase absolutely free from glutaminase activity, each batch of 
partially purified glutamate decarboxylase was checked. Test condition 
le for 30 minutes and test condition 4c for 300 minutes (Table l) 
were used to see whether a glutamate decarboxylase preparation was 
suitable for kinetic studies and to determine how much enzyme should be 
used at a certain incubation time while keeping the control relatively 
low. 
Figure 5 shows that at least the first one-third of the substrate 
is consumed linearly with time in the glutaminase assay. The assay is 
sensitive enough to detect 50 nmoles of substrate with confidence. The 
precision is restricted by pipetting error rather than the assay itself. 
Since the entire assay is run in a single test tube, no solution trans-
fer is necessary. Pipetting error is restricted to two possibilities: 
pipetting of the substrate and the sample solutions. One assay requires 
10 minutes for the reaction and 30 minutes for CO2 release and trapping; 
one extra minute is needed per additional assay, up to nine assays. 
Since glutamate decarboxylase is added after the glutaminase 
reaction has been stopped, the coupling system does not affect the 
assay . There is, therefore, no reason for assays to be done at sub-
optimal pH. The glutaminase react i on can be stopped and the conditions 
for glutamate decarboxylase activity can be achieved in a single step 
by changing the .PH from 8.8 to 4.5 with pyridine-HCl, since the phos-
phate-dependent glutaminase has a pH optimum around 8.8 and is irrever-
sibly damaged below pH 6.5, while glutamate decarboxylase has a pH 
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Minute 
Figure 5. Activity profile of glutaminase assay. The enzy~e has 
a specific activity of 2.5 µmole/~in/mg. 100 ~, of 0.2 M potassium 
phosphate buffer (pH 8.8) containing 0.22 mg protein was assayed 
according to the standard rr.ethod described under 11EXPER IMENTAL PROCE-
DURES. 11 The specificity of the substrate is 610 CPM/ 11mole 
glutamine. Each point represents the mean of two determinations. 
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Controls show that aITTTionia, up to 100 mM, and citrate, succinate, 
and glutarate up to 57 mM do not interfere with the assay. Nonenzy-
matic hydrolysis of glutamine is frequently a problem in glutaminase 
assays. However, it produces pyrollidoncarboxylic acid (166, 137) 
which is not a substrate for glutamate decarboxylase. Hence, substrate 
pretreatment is not necessary. It is still advisable to prepare fresh 
substrate solution just before use. 
Control experiments also show that the trapping solution is able 
to form carbamate with at least 40 ~moles of carbon dioxide (167). 
Also, there is no indication that diffused 2-aminoethanol (167) inhibits 
decarboxylation. 
Glutaminase Purification (Table 2) 
Acetone extraction removed most of the acetone soluble materials 
from the brain extract, disrupted the mitochondrial membranes, and 
rendered the glutaminase soluble. The possibility of protease action 
on glutaminase apparently was also eliminated by this treatment, since 
the enzyme was stable throughout the entire subsequent purification 
and showed a single band after sodium dodecyl sulfate gel electro-
phoresis. 
A solution of 20 mM sodium borate and 2 mM EDTA (pH 8. 6) was used 
to suspend the acetone powder. This buffer was used to aggregate and 
stablize glutaminase. It is necessary to use borate concentrations of 
20 mM or more; if the borate concentration used was 10 mM, for instance, 
the pH of the enzyme solution after the ammonium sulfate fractionation 
would be around 6.5. Glutaminase is not stable at this pH. If a 
buffer of 0.2 M potassium phosphate (pH 8.8) replaces 20 mM sodium 
Table 2. Purification of cow brain glutaminase 
Purification Step Protein Activity Specific Activity 






Ammonium Sul fate 
Calcium Phosphate 
Sepharose 4B Column I 


























The purification started with 1,670 g of cow brain after the removal of membrane. 
cEnzyme was dialyzed against 10 mM Tris-HCl, 100 mM potassium chloride, a.nd l mM dithiothreitol 







borate and 2 mM EDTA (pH 8.6) in suspending the acetone powder, the 
recovery after arm,onium sulfate fractionation is 20% higher, but the 
viscosity of the sample is so high that further purification is practi-
cally impossible. 
After the initial extraction, magnesium chloride and protamine 
sulfate were used to activate nucleotidases and to precipitate nucleic 
acids, respectively. Since the direct addition of nucleotidases to 
the sample did not decrease the 280/260 ratio and since addition of 
0. l g streptomycin per 100 ml sample eliminated the glutaminase acti -
vity completely, neither of these alternative procedure was adapted. 
Ammonium sulfate fractionation between 7% and 15% was very effec-
tive in removing impurities, as reflected by the increase of specific 
activity and the sharp decrease of total protein. Since the radio-
met ric assay was used, neither ammonium ions nor sulfate ions inter-
fered with the activity measurements. The 280/260 ratio decreased to 
0.5 at this stage, indicating that protein impurities had been removed 
more effectively than nucleic acids. 
Calcium phosphate gel treatment removed some nucleic acids, as 
judged by the increased 280/260 ratio and the decreased viscosity. 
Glutaminase was bound to the calcium phosphate gel in the absence of 
phosphate, and released by 0.2 M phosphate. Without this treatment 
the sample sticks to the top of chromatographic columns, making sepa-
rations impossible. 
Ultrafiltration served three purposes: (a) it concentrated the 
sample solution without changing the sample buffer, (b) it removed some 
impurities with molecular weights lower than 300,000, and (c) it 
decreased the viscosity of the sample since some viscous materials 
stuck to the membrane. 
Glutaminase aggregates in 0. l M potassium phosphate, 0. l M sodium 
pyrophosphate, and 10 mM sodium borate (pH 8.8) and dissociates in 
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10 mM Tris-HCl, 0. l M sodium pyrophosphate, and 0.2 mM dithiothreitol 
(pH 8.8). Most of the impurities do not show this behavior. Taking 
advantage of this, Sepharose 4B columns were used to differentiate 
glutaminase from impurities by eluting first with associating buffer and 
then with dissociating buffer. In the first column, glutaminase was 
highly aggregated and appeared slightly after the void volume (Figure 
6-a). In the second column, the glutaminase activity coincided with 
a minor protein peak that appeared well after the void volume (Figure 
6-b). This method is reproducible if the sample size is approximately 
the same. 
The overall yield of this purification was 12%, four times hiqher 
than that obtained for the pig brain enzyme (22). Based on weight, 
only one-tenth as much cow brain as pig brain is required to produce 
comparable activity. The specific activity of the acetone powder is 
ten times that of pig brain preparation. The final preparation had a 
specific activity of 385 ~mole/min/mg and showed a single protein band 
in polyacrylamide gel electrophoresis in sodium dodecyl sulfate (Figure 
7). In discontinuous polyacrylamide gel electrophoresis, a broad 
protein band one-fifth of the way down the gel and a band on the top 
of the gel were observed (Figure 8). The activity profile for this 
gel was coincided with the protein staining (Figure 9). This experi-
ment indicates that some of the sample was highly aggregated and was 
just barely able to get into the gel while the rest migrated for some 
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Figure 6. Elution profiles of Sepharose 4B columns equilibrated 
with 0. l M potassium phosphate, 0.1 M sodium pyrophosphate, and 10 mM 
sodium borate (pH 8.8) (a) and 10 mM Tris-HCl, 0.1 M sodium pyrophos-
phate, and 0.2 mM dithiothreiol {pH 8.8) (b). The arrows indicate the 
elution positions of void volumes. Experimental details were des-






Figure 7. Polyacrylamide gel electrophoresis of cow brain gluta-
minase in sodium dodecyl sulfate. 10 ~g of the final preparation was 
used per gel. The method is described under "EXPERIMENTAL PROCEDURES." 


Figure 8. Discontinuous polyacrylamide gel electrophoresis of cow 
brain glutaminase. 20 ~g of the final preparation in 0. l M potassium 
phosphate, 0. l M sodium pyrophosphate, and 10 rrM sodium borate (pH 8.8) 
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Figure 9. Glutaminase activity recovery from discontinuous poly-
acrylamide gel electrophoresis. Polyacrylamide gel electrophoresis of 
highly purified glutaminase in 0. l M potassium phosphate, 0. l M sodium 
pyrophosphate, and 10 mM sodium borate (pH 8.8). 10 ..ug enzyme 1tJas 
electrophoresed at room temperature. For measurement of activity, a 
parallel gel without protein staining was sliced into 25 slices, 2 mm 
each, after electrophoresis. Each slice was soaked in 200 ~l of 0.1 M 
potassium phosphate, 0. l M sodium pyrophosphate, and 10 mM sodium 
borate (pH 8.8) overnight at room temperature and then assayed. Elec-
trophoresis was perfonned according to II EXPERIMENTAL PROCEDURES. 11 
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distance into the gel. This total recovery from the gel was about 12%. 
The reason for the relatively low activity in the first slice is un-
known. The extraction may be incomplete, or some of the activity may 
remain in the stacking gel, or both. This is the first report that 
highly purified glutaminase would migrate into polyacrylamide gel and 
remain active in the absence of Triton X-100. 
A second parallel gel was sliced and soaked in 0. l M potassium 
phosphate, 0.1 M sodium pyrophosphate, and 10 rrM sodium borate (pH 8.8) 
as described in Figure 9, and each slice was then subjected to poly-
acrylamide gel electrophoresis in sodium dodecyl sulfate. \~hen this 
was done, a single band similar to the one shown in Figure 7 was 
observed, coincident with the enzyme activity profile and the protein 
staining shown in Figure 9. 
The 280/260 of the final preparation in 10 mM Tris-HCl, 0.1 M 
sodium pyrophosphate, and 0.2 mM dithiothreiol (pH 8.8) is 1.48. The 
ratio was l.l when the same preparation was dialyzed against 0.1 M 
potassium phosphate, 0.1 M sodium pyrophosphate, and 10 mM sodium 
borate (pH 8.8). These values are consisitent with results reported 
for pig kidney enzyme (132), where 280/260 is about 1.5 and 1.2 in the 
two buffers. 
Subunit Molecular Weiqht of Glutaminase 
Cow brain glutaminase shows a single protein band after poly-
acrylamide gel electrophoresis in sodium dodecyl sulfate (Figure 7). 
A single protein band suggests that this enzyme has not been subjected 
to protease action during purification. The subunit molecular weight 
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Figure 10. Estimation of cow brain glutaminase subunit molecular 
weight by electrophoresis on polyacrylamide gel in sodium dodecyl 
sulfate. 10 Dg of the final preparation was applied to the gel. The 
method is described under "EXPERIMENTAL PROCEDURES." The arrow indi-
cates the position of glutaminase. Abbreviations: ADC, arg1n1ne 
decarboxylase; BSA, bovine serum albumin; CAT, catalase; GOH, glutamate 
dehydrogenase; OA, ovalbumin. 
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is higher than that found for the pig brain and kidney enzymes (22, 26) 
but agrees well 1.'lith that of the rat kidney enzyme (71, 143). If the 
molecular weight of native cow brain glutaminase is close to that of 
other glutaminases, the subunit molecular \veight would suggest that 
the native enzyme is a dimer. 
Effect of pH On Activity and Stability 
The activity and stability of glutaminase as a function of pH are 
shown in Figure 11. The enzyme has highest activity at pH 8.8 regard-
less of the buffer that it was equilibrated with. In both phosphate 
and Tris-HCl buffers, the enzyme gave a similar activity curve whereas 
in phosphate-borate buffer a broader curve was observed. This result 
is consistent with all reports on phosphate-dependent glutaminase (24, 
131, 37, 25, 39, 48, 60, 124, 147, 59, 132, 34, 119, 75). 
When incubated in 0.2 M phosphate, glutaminase is stable over a 
fairly wide pH range; it retains essentially full activity from pH 7.5 
to 9.2. This pH stability plateau is a great advantage in the enzyme 
purification procedure; in this pH range no irreversible enzyme dena-
turation will occur. This stability curve is the first reported for 
glutaminase. 
Activators and Inhibitors of Glutaminase 
Figure 12 shows that glutaminase absolutely requires phosphate 
for activity; the equilibration buffer does not affect the results. 
The dependence on phosphate is sigmoidal and has a Hill coefficient of 
2.2. The phosphate concentration that gives half maximal velocity is 
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50 mM, consistent with that for the pig brain (68), pig kidney (87, 34), 
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Figure ll. Activity (--) and stability (- - -) of glutaminase 
as a function of pH. Experimental details are given in 11EXPERIMENTAL 
PROCEDURES. 11 The gl utaminase used for both experiments had a specific 
activity of 21 umole/min/mg. In both cases, parallel experiments 
without enzyme were conducted for pH measurements. The enzyme was 
equilibrated in 0. l M potassium phosphate (•), or 10 mM Tris-HCl and 
0.2 mM EDTA (0), or 10 mM sodium borate, 0. l M potassium phosphate, 
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Figure 12. Effect of phosphate on glutaminase. Enzyme with a 
specific activity of 24 J.Jmole/min/mg was dialyzed against 10 rr,M Tris-
HCl and lC mM EDTA (pH 8.5) (o) or 0.1 M potassium phosphate (pH 8.5) 
(e); the final protein concentrati ons were 0.2 and 0. 14 mg/ml, res-
pectively. 100 J.Jl of each solution was added to 200 J.Jl of 0.2 M 
glutamine containing potassium phosphate as appropriate (pH 8.5); 
assays were run at 32 C for 15 minutes. 
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and rat kidney (144) enzymes. In an additional experiment (not shown), 
glutaminase was equilibrated in 0.1 M potassium phosphate, 0.1 M sodium 
pyrophosphate, and 10 mM sodium borate (pH 8.5) and assayed in the 
presence of additional phosphate. If the concentrations of phosphate 
and pyrophosphate in the assay are summed, the results match those 
shown very closely. Since a phosphate dependent molecular weight 
change has been reported either to be correlated with phosphate acti-
vation (144) or to occur only at very high protein concentration (87, 
144, 71, 150), this complexity has been reduced as much as possible by 
minimizing the change of enzyme concentration in this experiment. 
Figure 13 shows that at high phosphate and low enzyme concentra-
tion, Km (the slope) and V are independent of the equilibration max 
buffer. This is consistent with the results in Figure 12 and with 
reports on pig and rat kidney glutaminases (34, 89, 25). It is not, 
hmvever, consistent with results reported for the pig brain enzyme, 
which suggest that it is an hysteretic enzyme that responds slowly to 
changes in ligand concentration (150). 
Succinate, citrate and glutarate do not affect cow brain gluta-
minase activity at either high (200 mM) or low (57 rrM) phosphate. In 
the experiment shown in Table 3, substrate solutions were 0.2 M gluta-
mine (pH 8.8), with or without 0.2 M potassium phosphate; carboxylic 
acid solutions were 50 mM (pH 8.8), with or without 0.2 M potassium 
phosphate. 100 ul of a carboxylic acid solution was added to 200 ul 
of a substrate solution before the addition of 100 ul of glutaminase in 
0.2 M potassium phosphate (pH 8.8). Assays were performed at 38 C for 































Figure 13. Effect of pretreatment on glutaminase. Highly 
purified glutaminase ~,as dialyzed against 10 mM Tris-HCl and 0.4 rr.M 
EDTA (o), o.l M potassiwr phosphate (o), and 0.1 M potassil..'ITl phosphate, 
0.1 M sodium pyrophosphate, and 10 rrM sodium borate(•), all at pH 8.5, 
to final protein concentrations of 0.48, 0.25, and 0.29 mg/ml, res-
pectively. 100 JJl of each solution was then added to 200 JJl of C.2 M 
potassium phosphate (pH 8.5) containing glutamine as - appropriate; 
assays were carried out at 38 C for 15 minutes. 
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Table 3. Effect of carboxylic acids on glutaminase activity 
Activity, umoles/min/ml, at 
Addi ti ens 
200 mM Pi 57 mM Pi 
None 10.4 3.3 
12.5 mM succinate 10.0 3.2 
12.5 mM glutarate 10.5 3.3 
12.5 mM citrate 10.2 3.2 
aThe enzyme had a specific activity of 21 unole/min/mg; 50 l.lg vJas 
used per assay. 
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rat brain (149) and pig brain (68) enzymes, which showed no significant 
activation due to carboxylic acid in the presence of 7.5 mM or higher 
phosphate. 
Figure 14 shows that ammonium ion concentrations up to 0.1 M do 
not affect the activity of the enzyme at 0.2 M phosphate. In this 
experiment, the enzyme was dissolved in 0.2 M potassium phosphate 
60 
buffer (pH 8.8) and had a specific activity of 1.2 µmole/min/mg. 100 lil 
of this solution containing 116 lig protein was added to 300 lil of a 
solution containing appropriate concentrations of glutamine, ammonium 
ion, and 0.2 M phosphate (pH 8.8); all assays were done at 38 C for 15 
minutes. 
Figure 14 also shows that decreasing phosphate concentrations de-
crease the apparent Vmax and increase Km (Kgln). It is not suprising 
that phosphate affucts both Kgln and Vmax· When reviewed separately, 
phosphate-caused decreases in K 1 have been reported for rat brain g n 
(149), dog kidney (119), pig kidney (132), and rat kidney (149) enzymes. 
All previous studies show that increasing phosphate increases the 
enzyme activity. The overall phosphate effect in Figure 14 is con-
sistent with the study of pig kidney enzyme (67). This result indicates 
that the activation role of phosphate cannot be filled by glutamine and 
that the binding sites for phosphate and glutamine are exclusive. 
Figures 15 and 16 show that glutamate is a competitive inhibitor 
for cow brain glutaminase at both high (200 mM) and low (50 mM) phos-
phate. At 200 rnM phosphate, the value for 
is 19 mM (Figure 15). At 50 mM phosphate, 
K obtained from the replot glu 
K 1 is 25 mM (Figure 16). g u 
When identical axes are used, the replots in Figures 15 and 16 are 
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Figure 14. Glutaminase activity at fixed concentrations of phos-
phate and anmonium ion. Round symbols: activity at 0 .2 M phosphate 
(pH 8. 8) with appropr i ate replacement of potassium by ammonium ion . 
The final concentration were 9 to 150 m'-1 glutamine in 0(0), 25(®), 
50(<J), or JOO(•) mM ammonilJTl ion and 0.2 M phosphate (pH 8.8). Open 
symbols: activity in the absence of ammoniLDTI ion. The final concen-
trations were 9 to 150 mM gl utamine in 50(0), 100(.6.), or 200(0) m'-1 
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Figure 15. Glutaminase activity at 0.2 M KPi and fixed concen-
trations of glutamate. The glutaminase in 0.2 M KPi (pH 8.8) had a 
specific activity of 1.2 JJIT1ole/ min/ mg. 116 119 protein in 100 vl solu-
tion ~,as added to 300 111 of a solution conta i ning approprie.te concen-
t rations of glutamine, glutamate, and 0.2 ~ KPi (pH 8.8); all assays 
were stepped after 15 minutes at 38 C. The final concentrations were 
9 to 15C mM glutamine in 0(0), 6.3(0). 12.5(©) or 25(e) mM glutamate, 
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Figure 16. Glutaminase acti vity at 50 mM KPi and fixed concen-
trations of glutamate. The enzyrr.€ in 50 mM KPi (pH 8.8) had a specific 
activity of 1.2 ~mole/min/mg. 116 ~g protein in 100 ~, solution was 
added to 300 ~, of a solution containing appropriate concentrations of 
glutamine, glutamate, and 50 mM KPi (p~: 8.8); all assays were stopped 
after 15 minutes incubation at 38 C. The final concentrations were 9 
to 150 m~1 glutamine in 0(O), 6.3(II), or 25(•) rrM glutamate and 50 mM 
KP i ( pH 8. 8) . 
competitive inhibition by glutamate is in agreement with the study of 
the pig kidney enzyme equilibrated with a Tris buffer (132, 67). Al-
though glutamate was shown to be a noncompetitive inhibitor for pig 
kidney glutaminase when the enzyme was equilibrated in either phosphate 
or phosphate-borate buffer, it has been observed that increasing the 
phosphate concentration can shift the noncompetitive inhibition to a 
competitive one (67). The effect of phosphate on glutaminase can not 
be interpreted in any simple way without additional experiments. 
In an additional experiment shown in Figure 17, K 1 was measured g n 
on the most highly purified cow brain glutaminase that was obtained. 
The slope in Figure 17 gives a value of 17 mM for K 1 . This value is g n 
about twice that of the pig brain enzyme (150, 68, 119). Although the 
enzyme source, enzyme purity, assay method, and assay conditions are 
not comparable among workers, it nevertheless appears that assays which 
use potassium phosphate consistently show a Kgln higher than those 
which use sodium phosphate (60, 59, 150, 68, 25, 89, 119). 
Mechanism of Action 
The results in Figure 14 show that ammonium ion up to 0. l M has no 
affect to the enzyme activity, suggesting that the release of ammonia 
may be irreversible. This is supported by the experiments shmAJn in 
Figure 18. 
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In the top experiment, ammonium ion was incubated with 14c-gluta-
mate in the presence of phosphate and glutaminase; cold glutamine was 
added as a carrier before chromatography. The radioactivity corres-
ponding to glutamine is 530 CPM for both the experiment and the control, 
indicating that no 14c-glutamine was formed from 14c-glutamate. The 
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Figure 17. Km of cow brain glutaminase. The enzyme has a specific 
activity of 360 Dmole/min/mg. 0.98 ug of enzyme in 100 ~l of 0.2 M 
potassium phosphate buffer (pH 8.8) was assayed with standard method 
stated in "EXPERIMENTAL PROCEDURES," except inq that the substrate con-
centration were those as indicated. One ~mole glutamine corresponds to 
415 CPM. Two sets of data are shown. 
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Figure 18. Reversibility of gl utami nase reaction. Top: 14c-
gl utamate and ammonium ion in 0.2 M phosphate buffer (pH 8.8) were in-
cubated in the absence ( o ) or presence ( x ) of gl utami nase and the 
mixture was chromatographed and counted as described under "EXPERI-
MENTAL PROCEDURES." The strip sho1,1m corresponds to the experiment vJith 
enzyme; the control without enzyme gives an identical pattern. Bottom: 
l4c-glutamate, ammonium ion, and glutamine in 0.2 M phosphate buffer 
(pH 8.8) were incubated in the absence ( o) or presence ( x) of gluta-
minase and the mixture was chromatographed and counted as described 
under "EXPERIMENTAL PROCEDURES.11 The paper strip corresponds to the 
experiment without enzyme; the experiment with enzyme present shows a 
very faint spot in the position of glutamine. Both experiments had a 
radioactivity recovery of about 83%. 
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lower experiment differs from the upper one in that cold glutamine was 
present in incubation. The radioactivity corresponding to glutamine 
was 1240 CPM for the control and 1280 CPM for the experiment. The 
ninhydrin stained strip of the experi ment (not shown) has a heavier 
spot corresponding to glutamate, and only a very faint spot corres-
ponding to glutamine. Although the 14c-glutamate appears to contain a 
substance that chromatographs in the same position as glutamine, it is 
clear that glutamine is not being formed from glutamate under these 
con di tons. If l % of the glutamate present had been converted to gl uta-
mi ne, the increase in radioactivity would have corresponded to 180 and 
330 CPM in the upper and lower chromatograms, respectively. This level 
could have been detected. 
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This observation that the glutaminase reaction is not significantly 
reversible is consistent with an irreversible release of NH3, as 
suggested by the inhibition data. Since all reports are consistent 
with a result that glutamate is an inhibitor, it is reasonable to 
suggest that its release is reversible. There are then two possible 
mechanisms for glutaminase action. One of these is shown in Figure 19. 
In the other mechanism, the order of product release is reversed. 
Nei ther mechanism makes any effort to assign a role to phosphate; 
the data available are not adequate for this purpose. 
Using a steady state approach, a rate equation for the mechanism 
shown in Figure 19 can be obtained. The derivation is shown in the 
Appendix. The result is 
vm 
V = --~------------
Kg l n Kqln 
l + [GLN] + [GLN] 
. [GLU] 
K gl u 
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Figure 19. The mechanism of action of glutaminase. 
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or V = vm - K (1 + [GLU])_v_ 
gln Kglu [GLN] 
( 2) 
From equation 2 it is clear that glutamate will not affect the intercept 
(apparent maximum velocity) but will alter the slope (apparent Km for 
glutamine); j_.~., glutamate will appear to inhibit competitively with 
respect to glutamine. This is consistent with the results in Figures 15 
and 16. 
Similar methods can be used to obtain a rate equation for the 
mechanism in which glutamate is the first product released. In this 
case, the result is: 
For this mechanism, then, the presence of glutamate should change both 
the intercept and the slope. 
The data presented here support the mechanism shown in Figure 19. 
This is consistent with the model of Klingman and Handler (34) but is 
not consistent with the dead-end complex models proposed by Tveit, 
Svenneby, and Kvamme (67, 132). Si nee homogeneous cow brain gl uta-
mi nase is now available, direct ligand binding studies should provide 
the evidence to confirm the mechanism of glutaminase. 
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APPENDIX 
The proposed mechanism is shown in Figure 19, page 68. Using the 
steady state assumption, 
d[E-Glu]/dt = k
3
[E-Gln] + k6[E][Glu] - k5[E-Glu] = 0 • 
d[E-Gln]/dt = k
1
[E][Gln] - (k2 + k3)[E-Gln] = 0 
From eqn. ( 1 ) : 
[E-Glu] = (k
3
[E-Gln] + k6[E][Glu])/k 5 
From eqn. ( 2) : 
[E-Gln] = k1[E][Gln]/(k 2 + k3) 





[E][Gln]/(k 2 + k3) + k6[E][Glu]/k 5 
or 
Now, [ET]= [E] + [E-Gln] + [E-Glu] ... 
Substituting eqns. (4) and (5) in eqn. (6), 






[ET]= [E](l + k1[Gln]/(k 2 + k3) + (k3k1[Gln]/(k 2 + K3) + k6[Glu]/k 5) 
or 
[E] = [ET]/(l + k1[Gln]/(k 2 + k3) + (k3k1[Gln]/(k 2 + k3) 
+ k6 [Glu])/k 5 ) 
Now, v = k5[E-Glu] - k6 [E][Glu] ..... 

















v = [E](k 3k1[Gln]/(k 2 + K3)) 
Substituting eqn. (7) in eqn. (9) gives 
79 
( 9) 
v = [ET]k1k3[Gln]/(k 2 + k3)(1 + k1[Gln]/(k 2 + k3) + k3k1[Gln]/(k 2 + k3) 
+ k6[Glu]/k 5 . . . . (10) 
Dividing top and bottom by k1(k3 +k5)[Gln]/k 5(k2 + k3) gives 
v = [ET]k3k5/(k 3 + k5)/(k 5(k2 + k3)/k 1(k3 + k5)[Gln] + 1 
+ k6k5(k2 + k3)[Glu]/k 5k1(k3 + k5)[Gln]) 
Definitions: Vm = k3k5[ET]/(k 3 + k5) 
Kglu = k5/k6 





+ [GLN] + [GLN] 
[GLU] 
K gl u 
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